Company: PACB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001299130-25-000156
Chunk: 10

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 10
---
,594 Net loss—— — — (468,005)(468,005)Other comprehensive loss—— — (155)— (155)Issuance of common stock in conjunction with equity plans5,9326 1,953 — — 1,959 Share-based compensation expense—— 21,096 — — 21,096 Balance at June 30, 2025300,350$300 $2,677,853 $267 $(2,616,931)$61,489 

Three Months Ended June 30, 2024Common StockAdditional Paid-inCapitalAccumulatedOtherComprehensiveLossAccumulated DeficitTotalStockholders'Equity(In thousands)SharesAmountBalance at March 31, 2024272,280$272 $2,566,304 $(306)$(1,917,253)$649,017 Net loss—— — — (173,319)(173,319)Other comprehensive loss—— — (217)— (217)Issuance of common stock in conjunction with equity plans211— — — — — Share-based compensation expense—— 17,219 — — 17,219 Balance at June 30, 2024272,491$272 $2,583,523 $(523)$(2,090,572)$492,700 

Six Months Ended June 30, 2024Common StockAdditional Paid-inCapitalAccumulatedOtherComprehensive Income (Loss)Accumulated DeficitTotalStockholders'Equity(In thousands)SharesAmountBalance at December 31, 2023267,744$268 $2,539,892 $219 $(1,839,075)$701,304 Net loss—— — — (251,497)(251,497)Other comprehensive loss—— — (742)— (742)Issuance of common stock in conjunction with equity plans4,7474 6,887 — — 6,891 Share-based compensation expense—— 36,744 — — 36,744 Balance at June 30, 2024272,491$272 $2,583,523 $(523)$(2,090,572)$492,700 

See accompanying notes to the condensed consolidated financial statements.

Q2 Fiscal 2025 Form 10-Q